Recent News

  • Fri, 01/25/2019 - 10:30

    Exfoliation syndrome is a leading cause of glaucoma worldwide. However, progress in developing better therapies for exfoliation glaucoma has been hindered by the lack of an animal model. Dr. John Fingert and Dr. Michael Anderson have received a two-year, $418,000 research award from the National Eye Institute to create and study animal models of exfoliation glaucoma using a genome editing approach.

  • Thu, 01/10/2019 - 16:00

    Post-doctoral fellow in the Glaucoma Genetics Lab, Ankur Jain, has been awarded a $50,000 Shaffer Grant for his proposal, "Autophagy-targeted Treatment for Myocilin-associated Glaucoma”. These funds will support his research to determine how gene-defects cause optic nerve damage and glaucoma.

  • Wed, 01/09/2019 - 09:00

    Dr. Fingert discusses myocilin mutations and how likely they are to cause glaucoma in an invited commentary in JAMA Ophthalmology. Read more about it here.